Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device

Delpor has exclusive rights to the patented technology and has several product candidates in development, including 3-6 month formulations of exenatide, liraglutide, and basal insulin. SAN FRANCISCO, CA, April 23, 2015 – Delpor, Inc. (Delpor), [...]

By |2018-01-02T19:57:24+00:00April 23rd, 2015|News|0 Comments